Open access · CC-BY
via OpenAlex
Epigenetic brain reprogramming rejuvenates neuro-immune circuits to reverse Alzheimer’s disease pathology and systemic bone loss
Mei-dan Wan, Xixi Liu, Tengfei Wan, Yi-Wei Liu, Ya-Ling Jiang, Jingtao Zou, Bin Jiao, Qian-Qian Liu, Ling Jin, Ran Duan, Zi Wang, Chun‐Gu Hong, Xin Wang, Xin-Yue Hu, Xin-Xin Liao
Journal of Neuroinflammation · 2026
Epigenetic alterations
Altered intercellular communication
Chronic inflammation
Partial reprogramming (OSK)
Mouse
Abstract
Alzheimer’s disease (AD) is characterized by progressive neurodegeneration, neuroinflammation, and systemic comorbidities, yet disease-modifying therapies remain elusive. Here, we show that partial epigenetic reprogramming via brain-restricted expression of Oct4, Sox2, and Klf4 (OSK) restores neuronal and neuroimmune homeostasis without loss of cellular identity. In APP/PS1 mice, OSK reprogramming improves cognitive performance across disease stages, reduces amyloid-β deposition, attenuates microglial activation, preserves synaptic integrity, and limits neuronal apoptosis. Mechanistically, reduced representation bisulfite sequencing reveals widespread reversal of AD-associated DNA methylation patterns, which is dependent on Tet2-mediated demethylation, establishing epigenetic rejuvenation as a key driver of functional recovery. Unexpectedly, brain-restricted OSK reprogramming also ameliorates systemic bone loss by reshaping brain-derived extracellular vesicle signaling, including modulation of miR-483-5p, thereby restoring osteogenic capacity. Together, these findings identify partial epigenetic reprogramming as a strategy to rewire neuro-immune circuits and link central nervous system rejuvenation to peripheral tissue homeostasis, providing a conceptual framework for targeting both neurodegeneration and its systemic consequences in AD. Localized OSK-mediated epigenetic reprogramming in the hippocampus rejuvenates neuronal and microglial epigenomes via Tet2-dependent DNA demethylation, thereby suppressing Aβ deposition, neuroinflammation and apoptosis to restore cognition in AD, while also mitigating associated bone loss through modulation of brain-derived EV cargo
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1186/s12974-026-03854-8
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Wan, M., Liu, X., Wan, T., Liu, Y., Jiang, Y., Zou, J., Jiao, B., Liu, Q., Jin, L., Duan, R., Wang, Z., Hong, C., Wang, X., Hu, X., Liao, X., Cao, J., Shen, L., Xie, H., & Wang, Z. (2026). Epigenetic brain reprogramming rejuvenates neuro-immune circuits to reverse Alzheimer’s disease pathology and systemic bone loss. <em>Journal of Neuroinflammation</em>. https://doi.org/10.1186/s12974-026-03854-8
Vancouver
Wan M, Liu X, Wan T, Liu Y, Jiang Y, Zou J, et al. Epigenetic brain reprogramming rejuvenates neuro-immune circuits to reverse Alzheimer’s disease pathology and systemic bone loss. Journal of Neuroinflammation. 2026. doi:10.1186/s12974-026-03854-8.
BibTeX
@article{meidan2026Epigen,
title = {Epigenetic brain reprogramming rejuvenates neuro-immune circuits to reverse Alzheimer’s disease pathology and systemic bone loss},
author = {Mei-dan Wan and Xixi Liu and Tengfei Wan and Yi-Wei Liu and Ya-Ling Jiang and Jingtao Zou and Bin Jiao and Qian-Qian Liu and Ling Jin and Ran Duan and Zi Wang and Chun‐Gu Hong and Xin Wang and Xin-Yue Hu and Xin-Xin Liao and Jia Cao and Lu Shen and Hui Xie and Zhen-Xing Wang},
journal = {Journal of Neuroinflammation},
year = {2026},
doi = {10.1186/s12974-026-03854-8},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Annals of Neurology 2022
Open access · CC-BY
Microglial Activation and Connectivity in Alzheimer Disease and Aging
Current Stem Cell Research & Therapy 2025
Citation only
Can iPSCs Turn Back Time? Prospects and Pitfalls in Age Reversal
Current stem cell research & therapy 2026
Citation only
Can iPSCs Turn Back Time? Prospects and Pitfalls in Age Reversal.
PLoS Medicine 2018
Open access · CC-BY
Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study
Journal of Biological Chemistry 2010
Open access · CC-BY
AMP-activated Protein Kinase Signaling Activation by Resveratrol Modulates Amyloid-β Peptide Metabolism
Mechanisms of ageing and development 2026
Citation only